US Food and Drug Administration
Silver Spring, Maryland
Tannaz Ramezanli currently serves as pharmacologist within the Office of Research and Standard (ORS) at Office of Generic Drugs (OGD) at the U.S. FDA. She currently work as a reviewer in the Topical and Transdermal Team at ORS. She is responsible for the development of product-specific bioequivalence guidances, reviewing and responding to controlled correspondences, and Pre-ANDA meetings. Tannaz Ramezanli is also engaged in the development of regulatory science research initiatives related to topical and transdermal drug products through FDA-funded collaborations with research institutions around the world. She received her Ph.D. in Pharmaceutical Sciences from Rutgers University and her Pharm.D. from Tehran University of Medical Sciences.